Pharmaceutical Gelatin Market Size (2024 - 2029)

The pharmaceutical gelatin market is projected to experience growth over the forecast period, driven by an increasing demand for pharmaceutical-grade gelatin and advancements in drug delivery systems. The market's expansion is supported by the material's applications in drug delivery, wound healing, and tissue engineering, among others. Despite challenges such as the rise in veganism and cultural restrictions, the market is expected to benefit from the biocompatibility and biodegradability of gelatin, particularly in parenteral formulations. The post-pandemic recovery and the introduction of new products are also anticipated to contribute to the market's growth trajectory.

Home Market Analysis Healthcare Research Device Drug Combination Research Co-Packages Research Therapeutic Products Research Medical Gel Research Pharmaceutical Gelatin Market Market Size

Market Size of Pharmaceutical Gelatin Industry

Pharmaceutical Gelatin Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 5.80 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Pharmaceutical Gelatin Market Major Players

*Disclaimer: Major Players sorted in no particular order

Pharmaceutical Gelatin Market Analysis

The pharmaceutical gelatin market is expected to register a CAGR of 5.5% over the forecast period.

COVID-19 had a significant impact on gelatin production and the supply chain since the import and export of capsules and gelatin-based products were halted due to pandemic restrictions. Gelatin was found to be important in the COVID-19 treatment. For instance, according to the study published in May 2022 by PubMed, the addition of gelatin to the drug delivery significantly stabilizes the proteins and enhances the fractions of active proteins after nebulization, minimizing the medication dosage. In the post-pandemic scenarios, the market is anticipated to witness growth owing to the rise in product launches, the rise in demand for pharmaceutical-grade gelatin, and research and development in gelatin-based products.

The factors driving the growth of the pharmaceutical gelatin market include rising demand for pharmaceutical-grade gelatin, the increasing burden of chronic disease, the rise in the geriatric population, and the growing advancements of gelatin nanoparticles in drugs and vaccines, among others. The rising application of gelatin in cosmetic applications, intrinsic activities, and biomedical applications in wound dressing and wound healing, gene therapy, tissue engineering, implants, and bone substitutes is driving market growth. For instance, according to the study published in March 2021 in PubMed, pharmaceutical gelatin has wide applications in the manufacturing of capsules, coating of microparticles or oils, coating of tablets, stabilization of emulsions, and drug delivery (microspheres, nanospheres, scaffolds, microneedles, and hydrogels). Furthermore, according to the same source, gelatin obtained from fish is immunologically safe, protects against the possibility of transmission of bovine spongiform encephalopathy and foot-and-mouth diseases, and has economic and environmental benefits. Such added benefits of gelatin in the pharmaceutical industry are likely to drive market growth.

In addition, the rise in the advancement of gelatin in drug delivery is likely to drive the market growth of pharmaceutical gelatin over the forecast period. For instance, according to the study published in November 2021 in Springer Link, gelatin is a natural, biodegradable, and biocompatible material that can be used to deliver drugs for tumor therapy, including resveratrol, cycloheximide, and doxorubicin. Due to their low cost, biocompatibility, biodegradability, limited antigenicity, and use in a variety of formulations, gelatin nanoparticles have been proposed as a choice for parenteral formulations. This is anticipated to boost the adoption of gelatin in parenteral drug delivery systems, thereby driving market growth.

Therefore, due to the rise in the advancements offered by gelatin and the increase in demand for pharmaceutical-grade gelatin, the pharmaceutical gelatin market is anticipated to witness growth over the forecast period. However, the rising trend in veganism and cultural restrictions, as well as side effects associated with animal-derived gelatin in humans, among others, are expected to hinder market growth.

Pharmaceutical Gelatin Industry Segmentation

As per the scope of the report, gelatin refers to a translucent, colorless, and flavorless water-soluble protein derived from collagen taken from animal body parts, such as bones, skin, etc. Gelatin contains both cationic and anionic groups; hence, it is considered a poly-ampholyte. Pharmaceutical-grade gelatin is the type of gelatin used primarily to make hard and soft gelatin capsules. Other uses include making tablets, syrups, etc. The pharmaceutical gelatin market is segmented by application (capsules, tablets, and other applications), source (porcine, bovine, and other sources), and geography (North America, Europe, Asia Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Application
Capsules
Tablets
Other Applications
By Source
Porcine
Bovine
Other Sources
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Pharmaceutical Gelatin Market Size Summary

The pharmaceutical gelatin market is poised for growth, driven by increasing demand for pharmaceutical-grade gelatin and advancements in gelatin-based drug delivery systems. The market is recovering from the disruptions caused by the COVID-19 pandemic, which highlighted gelatin's importance in stabilizing proteins for drug delivery. The rising application of gelatin in various biomedical fields, such as wound healing, gene therapy, and tissue engineering, further propels market expansion. Additionally, the geriatric population's growing need for prescription drugs and the rising prevalence of chronic diseases are significant factors contributing to the market's upward trajectory. The market is also witnessing innovations in gelatin capsule manufacturing, with key players investing in new technologies and products to meet the evolving demands of the healthcare sector.

North America holds a dominant position in the pharmaceutical gelatin market, supported by a robust healthcare infrastructure and the availability of raw materials. The region's market growth is fueled by the high prevalence of chronic diseases, leading to increased medication adoption and, consequently, a higher demand for gelatin capsules. The introduction of new gelatin brands and the expansion of capsule manufacturing services further bolster the market in this region. Globally, the market remains moderately competitive, with major players like Darling Ingredients Inc., NITTA GELATIN, INC., and Gelita AG leading the charge. These companies are expected to continue shaping the market landscape through strategic expansions and product innovations, catering to the growing need for pharmaceutical-grade gelatin in various applications.

Explore More

Pharmaceutical Gelatin Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Demand for Pharmaceutical Grade Gelatin

      2. 1.2.2 Increasing Burden of Chronic Disease, along with Rise in Geriatric Population

      3. 1.2.3 Growing Advancemnets of Gelatin Nanoparticles in Drug and Vaccine

    3. 1.3 Market Restraints

      1. 1.3.1 Rising Trend in Veganism and Culture Restrictions

      2. 1.3.2 Side Effects Associated with Animal Derived Gelatin in Humans

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Buyers/Consumers

      2. 1.4.2 Bargaining Power of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Application

      1. 2.1.1 Capsules

      2. 2.1.2 Tablets

      3. 2.1.3 Other Applications

    2. 2.2 By Source

      1. 2.2.1 Porcine

      2. 2.2.2 Bovine

      3. 2.2.3 Other Sources

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Pharmaceutical Gelatin Market Size FAQs

The Pharmaceutical Gelatin Market is projected to register a CAGR of 5.80% during the forecast period (2024-2029)

Gelita AG, Weishardt, Darling Ingredients Inc, Tessenderlo Group (PB Leiner) and NITTA GELATIN, INC are the major companies operating in the Pharmaceutical Gelatin Market.

Pharmaceutical Gelatin Market Report Snapshots

Pharmaceutical Gelatin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)